Rationale for combined therapies in severe-to-critical COVID-19 patients

An unprecedented global social and economic impact as well as a significant number of fatalities have been brought on by the coronavirus disease 2019 (COVID-19), produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute SARS-CoV-2 infection can, in certain situations, cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzaga, Aitor, Andreu, Etelvina, Hernández-Blasco, Luis M., Meseguer, Rut, Al-Akioui-Sanz, Karima, Soria-Juan, Bárbara, Sanjuan-Gimenez, Jose Carlos, Ferreras, Cristina, Tejedo, Juan R., Lopez-Lluch, Guillermo, Goterris, Rosa, Maciá, Loreto, Sempere-Ortells, Jose M., Hmadcha, Abdelkrim, Borobia, Alberto, Vicario, Jose L., Bonora, Ana, Aguilar-Gallardo, Cristobal, Poveda, Jose L., Arbona, Cristina, Alenda, Cristina, Tarín, Fabian, Marco, Francisco M., Merino, Esperanza, Jaime, Francisco, Ferreres, José, Figueira, Juan Carlos, Cañada-Illana, Carlos, Querol, Sergio, Guerreiro, Manuel, Eguizabal, Cristina, Martín-Quirós, Alejandro, Robles-Marhuenda, Ángel, Pérez-Martínez, Antonio, Solano, Carlos, Soria, Bernat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520558/
https://www.ncbi.nlm.nih.gov/pubmed/37767093
http://dx.doi.org/10.3389/fimmu.2023.1232472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520558/
https://www.ncbi.nlm.nih.gov/pubmed/37767093
http://dx.doi.org/10.3389/fimmu.2023.1232472

Ejemplares similares